WHO ICTRP trial
Exploratory trial of a combination therapy of Gemcitabine and immunotherapy…
JPRN-UMIN000026187 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000026187 |
|---|---|
| Public title | Exploratory trial of a combination therapy of Gemcitabine and immunotherapy against pancreatic cancer. |
| Scientific title | Exploratory trial of a combination therapy of Gemcitabine and immunotherapy against pancreatic cancer. - Exploratory trial of a combination therapy of Gemcitabine and immunotherapy against pancreatic cancer. |
| Primary sponsor | Department of Gastroenterology and Hepatology, Shool of Medicine, Kochi University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | pancreatic cancer |
| Interventions | A combined chemoimmunotherapy of Gemcitabine plus WT1-W10 peptide vaccine |
| Registration date | Feb 20, 2017 |
| Target size | 6 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: